Drugs / ASKB1202
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03115762 | Jun → Jul 2017 | — | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASKB1202 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03115762 ↗ |
| Route | Intravenous | “Subject to receive one intravenous (i.v.) infusion of ASKB1202” NCT03115762 ↗ |